TAM
MACK

Tocqueville Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Tocqueville Asset Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,462
Closed -$98K – 981
2015
Q3 		$98K Sell
1,462
-8,897
-86% -$726K ﹤0.01% 926
2015
Q2 		$1.01M Sell
10,359
-826
-7% -$78.6K 0.01% 571
2015
Q1 		$1.04M Sell
11,185
-254
-2% -$21.6K 0.01% 576
2014
Q4 		$1.02M Buy
11,439
+3,813
+50% +$278K 0.01% 576
2014
Q3 		$527K Sell
7,626
-6,050
-44% -$323K 0.01% 606
2014
Q2 		$784K Buy
13,676
+5,796
+74% +$294K 0.01% 626
2014
Q1 		$312K Buy
7,880
+3,431
+77% +$147K ﹤0.01% 691
2013
Q4 		$187K Buy
+4,449
New +$129K ﹤0.01% 816
2013
Q3 		– Sell
-6,298
Closed -$334K – 967
2013
Q2 		$334K Buy
+6,298
New +$276K ﹤0.01% 747

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Tocqueville Asset Management's MACK Position: Q4 2015 in Review

Tocqueville Asset Management sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2015, closing a stake of 1,462 shares — an estimated $98K sold.

Tocqueville Asset Management first reported a position in MACK in Q2 2013 and held it in 9 quarters. The position peaked at $1.04M in Q1 2015. 139 funds tracked by Wall St. Rank hold MACK as of Q4 2015.

  • Tocqueville Asset Management reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Tocqueville Asset Management sold 1,462 Merrimack Pharmaceuticals, Inc. shares in Q4 2015, an estimated $98K.
  • Tocqueville Asset Management first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 9 quarters.
  • Tocqueville Asset Management's Merrimack Pharmaceuticals, Inc. position peaked at $1.04M in Q1 2015.
  • 139 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2015.

Based on Tocqueville Asset Management's 13F filing for Q4 2015, filed 29 Jan 2016.